Financial Summary (All financials)
| In millions, except per share items | Feb-03-23 | Jan-28-22 | Jan-29-21 | Jan-31-20 | Feb-01-19 | Feb-02-18 | Dec-31-16 | Dec-31-15 |
| Revenues | 13,350.0 | 12,851.0 | 11,767.0 | 10,811.0 | 9,613.0 | 8,336.0 | 5,968.0 | 6,571.0 |
| Revenue growth | 3.9% | 9.2% | 8.8% | 12.5% | 15.3% | | -9.2% | 8.9% |
| Cost of goods sold | 1,801.0 | 2,271.0 | 2,043.0 | 1,799.0 | 1,552.0 | 1,511.0 | 0.0 | 1,018.0 |
| Gross profit | 11,549.0 | 10,580.0 | 9,724.0 | 9,012.0 | 8,061.0 | 6,825.0 | 5,968.0 | 5,553.0 |
| Gross margin | 86.5% | 82.3% | 82.6% | 83.4% | 83.9% | 81.9% | 100.0% | 84.5% |
| Sales and marketing | 4,767.0 | 4,067.0 | 3,711.0 | 3,677.0 | 3,230.0 | 2,723.0 | 2,307.0 | 2,267.0 |
| Research and development | 3,933.0 | 3,057.0 | 2,816.0 | 2,522.0 | 2,173.0 | 1,917.0 | 1,503.0 | 1,300.0 |
| General and administrative | 1,296.0 | 1,068.0 | 767.0 | 1,293.0 | 846.0 | 722.0 | 689.0 | 766.0 |
| EBITA | 2,030.0 | 2,691.0 | 2,758.0 | 1,820.0 | 2,059.0 | 1,642.0 | 1,598.0 | 1,266.0 |
| EBITA margin | 15.2% | 20.9% | 23.4% | 16.8% | 21.4% | 19.7% | 26.8% | 19.3% |
| Amortization of intangibles | | 303.0 | 328.0 | 300.0 | 247.0 | 179.0 | 129.0 | 145.0 |
| EBIT | 2,030.0 | 2,388.0 | 2,430.0 | 1,520.0 | 1,812.0 | 1,463.0 | 1,469.0 | 1,121.0 |
| EBIT margin | 15.2% | 18.6% | 20.7% | 14.1% | 18.8% | 17.6% | 24.6% | 17.1% |
| Pre-tax income | 1,792.0 | 2,085.0 | 2,382.0 | 1,438.0 | 1,829.0 | 1,577.0 | 1,503.0 | 1,213.0 |
| Income taxes | 478.0 | 265.0 | 324.0 | -4,918.0 | 239.0 | 1,152.0 | 280.0 | 216.0 |
| Tax rate | 26.7% | 12.7% | 13.6% | | 13.1% | 73.1% | 18.6% | 17.8% |
| Net income | 1,314.0 | 1,820.0 | 2,058.0 | 6,412.0 | 1,650.0 | 437.0 | 1,223.0 | 997.0 |
| Net margin | 9.8% | 14.2% | 17.5% | 59.3% | 17.2% | 5.2% | 20.5% | 15.2% |
| |
| Diluted EPS | $3.09 | $4.31 | $4.86 | $15.08 | $3.92 | $1.04 | $2.88 | $2.34 |
| Shares outstanding (diluted) | 425.9 | 422.4 | 423.2 | 425.2 | 421.1 | 420.9 | 424.0 | 426.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|